Navigation Links
Progen Investor Teleconference Dial In Details
Date:2/4/2008

BRISBANE, Australia, Feb. 4 /PRNewswire-FirstCall/ -- Progen Pharmaceuticals' Management Team (ASX: PGL; Nasdaq: PGLA) will be conducting an investor teleconference on Tuesday 5 February at 9.00am Australian (Sydney time) and Monday 4 February at 5:00pm US EST.

The Management Team will present an overview of the Cellgate, Inc. acquisition and will be available to answer your queries.
Please refer to the relevant presentation at: http://www.progen-pharma.com

Please follow the dial-in instructions below:

National toll free - Australia - 1800 701 269

Country International Time of Teleconference call

toll free numbers: in the relevant locations

United Kingdom 1080 0264 0084 Monday, 4 February 2008 at 10:00 PM

Hong Kong 800 968 831 Tuesday, 5 February 2008 at 6:00 AM

Japan 0053 125 0068 Tuesday, 5 February 2008 at 7:00 AM

Singapore 800 616 3092 Tuesday, 5 February 2008 at 6:00 AM

Taiwan 008 0161 5152 Tuesday, 5 February 2008 at 6:00 AM

New Zealand 080 044 6041 Tuesday, 5 February 2008 at 11:00 AM

USA 1866 2421 388 Monday, 4 February at 2.00 PM PST

Monday, 4 February at 5.00 PM EST

International toll - + 61 2 8823 6760

Then dial conference identification number: 33563946

If your country is not listed, and you would like to participate on the call, please contact Cindy Ingram on +61 7 3842 3333 or cindyi@progen- pharma.com and she will provide you with the appropriate toll free number.

About Progen: Progen Pharmaceuticals Limited is an Australia-based globally focused biotechnology company committed to the discovery, development and commercialization of small molecule therapeutics primarily for the treatment of cancer.


'/>"/>
SOURCE Progen Pharmaceuticals Limited
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Elusive pancreatic progenitor cells found in mice
2. Imaging neural progenitor cells in the living human brain
3. Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
4. Progen to Present Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
5. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
6. Stryker to Present at Investor Conference
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 5, 2008
8. GSI to Present at Upcoming Investor Growth Conferences
9. WebMD to Present at Upcoming Investor Conferences
10. Immtech Investor Conference Call Scheduled for January 3, 2008, at 1 PM
11. Mindray to Attend 2008 CLSA Asia Investors Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations ... Latin America . ... ... ... ...
Breaking Medicine Technology: